{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:17Z","timestamp":1786985597909,"version":"build-2736575974"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National HIV Surveillance System Project","award":["5U62PS004022-04"],"award-info":[{"award-number":["5U62PS004022-04"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.canep.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T20:03:09Z","timestamp":1511467389000},"page":"20-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Changing temporal trends in non-AIDS cancer mortality among people diagnosed with AIDS: San Francisco, California, 1996\u20132013"],"prefix":"10.1016","volume":"52","author":[{"given":"Nancy A.","family":"Hessol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Scheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra K.","family":"Schwarcz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.canep.2017.11.004_bib0005","doi-asserted-by":"crossref","first-page":"397","DOI":"10.7326\/0003-4819-145-6-200609190-00003","article-title":"Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City","volume":"145","author":"Sackoff","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"issue":"9939","key":"10.1016\/j.canep.2017.11.004_bib0015","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","article-title":"Trends in underlying causes of death in people with HIVfrom 1999 to 2011 (D:A:D): a multicohort collaboration","volume":"384","author":"Smith","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.canep.2017.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/652283","article-title":"Causes of death in HIV-1-infected patients treated with antiretroviral therapy, 1996\u20132006: collaborative analysis of 13 HIV cohort studies","volume":"50","year":"2010","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.canep.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cid\/ciu261","article-title":"Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients","volume":"59","author":"Ingle","year":"2014","journal-title":"Clin Infect Dis."},{"issue":"4","key":"10.1016\/j.canep.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1468-1293.2012.01051.x","article-title":"Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study","volume":"14","author":"Weber","year":"2013","journal-title":"HIV Med."},{"issue":"8","key":"10.1016\/j.canep.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1097\/QAD.0000000000000222","article-title":"Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000","volume":"28","author":"Morlat","year":"2014","journal-title":"AIDS"},{"issue":"8","key":"10.1016\/j.canep.2017.11.004_bib0040","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/QAD.0b013e328329216a","article-title":"Non-AIDS-defining malignancies in HIV-infected persons: etiologic puzzles, epidemiologic perils, prevention opportunities","volume":"23","author":"Engels","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.canep.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.canep.2017.11.004_bib0050","series-title":"AIDS-Defining Conditions","author":"Centers for Disease Control and Prevention (CDC)","year":"2008"},{"issue":"14","key":"10.1016\/j.canep.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.2011.396","article-title":"Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980\u20132007","volume":"305","author":"Shiels","year":"2011","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.canep.2017.11.004_bib0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1089\/apc.2014.0079","article-title":"Changes in causes of death among persons with AIDS: San Francisco, California, 1996\u20132011","volume":"28","author":"Schwarcz","year":"2014","journal-title":"AIDS Patient Care STDS"},{"issue":"8","key":"10.1016\/j.canep.2017.11.004_bib0065","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1086\/656416","article-title":"Cancer as a cause of death among people with AIDS in the United States","volume":"51","author":"Simard","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.canep.2017.11.004_bib0070","series-title":"Health, HIV Epidemiology Annual Report 2015","author":"San Francisco Department of Public Health","year":"2015"},{"key":"10.1016\/j.canep.2017.11.004_bib0075","first-page":"1","article-title":"Centers for disease, prevention, revised surveillance case definition for HIV infection\u2013United States, 2014","volume":"03","year":"2014","journal-title":"MMWR Recomm. Rep."},{"key":"10.1016\/j.canep.2017.11.004_bib0080","unstructured":"U.S. Census Bureau 2006\u20132010 American Community Survey. 2010, 2010. http:\/\/www.census.gov\/programs-surveys\/acs\/data\/summary-file.2010.html. (Accessed July 15 2016)."},{"key":"10.1016\/j.canep.2017.11.004_bib0085","unstructured":"Physician\u2019s Handbook on Medical Certification of Death, 2003 Revision, Department of Health and Human Services. Centers for Disease Control and Prevention. National Center for Health Statistics. DHHS Publication No: (PHS) 2003\u20131108."},{"key":"10.1016\/j.canep.2017.11.004_bib0090","series-title":"International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)","author":"CDC","year":"1979"},{"key":"10.1016\/j.canep.2017.11.004_bib0095","series-title":"International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)","author":"CDC","year":"1999"},{"key":"10.1016\/j.canep.2017.11.004_bib0100","unstructured":"National Center for Health Statistics. National Death Index user\u2019s guide; Appendix B. Hyattsville, MD. 2013."},{"key":"10.1016\/j.canep.2017.11.004_bib0105","unstructured":"State of California, Department of Finance, Race\/Hispanics Population with Age and Gender Detail, 2000\u20132010. Sacramento, California, September 2012."},{"key":"10.1016\/j.canep.2017.11.004_bib0110","unstructured":"State of California, Department of Finance, Race\/Ethnic Population with Age and Sex Detail, 1990\u20131999. Sacramento, CA, Revised May 2009."},{"key":"10.1016\/j.canep.2017.11.004_bib0115","unstructured":"SAS Institute Inc, SAS\/STAT User's Guide, Version 9.4, SAS Institute Inc., Cary, North Carolina, 2014."},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0120","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/QAD.0000000000000873","article-title":"Rectal squamous cell carcinoma in immunosuppressed populations: is this a distinct entity from anal cancer?","volume":"30","author":"Coghill","year":"2016","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.canep.2017.11.004_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.canlet.2011.02.007","article-title":"HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies","volume":"305","author":"Da Silva","year":"2011","journal-title":"Cancer lett."},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0130","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/135965350601100104","article-title":"Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity","volume":"11","author":"Jansen","year":"2006","journal-title":"Antivir. Ther."},{"issue":"3","key":"10.1016\/j.canep.2017.11.004_bib0135","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00002030-200402200-00015","article-title":"Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia","volume":"18","author":"Bourboulia","year":"2004","journal-title":"AIDS (London, England)"},{"issue":"2","key":"10.1016\/j.canep.2017.11.004_bib0140","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/jac\/dkq448","article-title":"Emerging antiretroviral drug interactions","volume":"66","author":"Pham","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.canep.2017.11.004_bib0145","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Adolescents, Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents, 2016. http:\/\/www.aidsinfo.nih.gov\/ContentFiles\/Adul-tandAdolescentGL.pdf. (Accessed July 28 2016)."},{"issue":"21","key":"10.1016\/j.canep.2017.11.004_bib0150","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1182\/blood.V122.21.4372.4372","article-title":"Comparative Outcomes of Chemotherapy with and without HAART for HIV-Related B-Cell Lymphoma: A Meta-Analysis","volume":"122","author":"Shah","year":"2013","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.canep.2017.11.004_bib0155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin. Infect. Dis.: An official publication of the Infectious Diseases Society of America"},{"issue":"10","key":"10.1016\/j.canep.2017.11.004_bib0160","doi-asserted-by":"crossref","first-page":"728","DOI":"10.7326\/0003-4819-148-10-200805200-00005","article-title":"Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003","volume":"148","author":"Patel","year":"2008","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.canep.2017.11.004_bib0165","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10552-015-0615-3","article-title":"Alcohol consumption and liver cancer risk: a meta-analysis","volume":"26","author":"Chuang","year":"2015","journal-title":"Cancer causes control : CCC"},{"issue":"10","key":"10.1016\/j.canep.2017.11.004_bib0170","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1111\/acer.13204","article-title":"Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions","volume":"40","author":"Williams","year":"2016","journal-title":"Alcohol. Clin. Exp. Res."},{"issue":"Suppl 3","key":"10.1016\/j.canep.2017.11.004_bib0175","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1097\/01.aids.0000192065.09281.01","article-title":"HIV, hepatitis C and HIV\/hepatitis C virus co-infection in vulnerable populations","volume":"19","author":"Backus","year":"2005","journal-title":"AIDS (London, England)"},{"issue":"4","key":"10.1016\/j.canep.2017.11.004_bib0180","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects","volume":"188","author":"Kellerman","year":"2003","journal-title":"J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.canep.2017.11.004_bib0185","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1097\/QAD.0000000000000690","article-title":"Lung cancer incidence and survival among HIV-infected and uninfected women and men","volume":"29","author":"Hessol","year":"2015","journal-title":"AIDS (London, England)"},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0190","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1086\/518606","article-title":"HIV infection is associated with an increased risk for lung cancer, independent of smoking","volume":"45","author":"Kirk","year":"2007","journal-title":"Clin. Infect. Dis.: An official publication of the Infectious Diseases Society of America"},{"issue":"4","key":"10.1016\/j.canep.2017.11.004_bib0195","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/0956462413499317","article-title":"Lung cancer in HIV-infected patients","volume":"25","author":"Palacios","year":"2014","journal-title":"Int. J. STD AIDS"},{"issue":"3","key":"10.1016\/j.canep.2017.11.004_bib0200","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/QAI.0b013e3181eef4f7","article-title":"Pulmonary Infections and Risk of Lung Cancer Among Persons With AIDS","volume":"55","author":"Shebl","year":"2010","journal-title":"Jaids-J Acq Imm Def"},{"issue":"5","key":"10.1016\/j.canep.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/sextrans-2015-052121","article-title":"Anal HPV detection in men who have sex with men living with HIV who report no recent anal sexual behaviours: baseline analysis of the Anal Cancer Examination (ACE) study","volume":"92","author":"Ong","year":"2016","journal-title":"Sex. Transm. Infect."},{"issue":"5","key":"10.1016\/j.canep.2017.11.004_bib0210","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1097\/00002030-199805000-00011","article-title":"High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men","volume":"12","author":"Palefsky","year":"1998","journal-title":"AIDS (London, England)"},{"key":"10.1016\/j.canep.2017.11.004_bib0215","article-title":"Non-AIDS Defining Cancer Mortality: Emerging Patterns in the Late HAART Era,)","volume":"1999","author":"Zucchetto","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"3","key":"10.1016\/j.canep.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.qai.0000164033.02947.e3","article-title":"Survival After Cancer Diagnosis in Persons With AIDS, (1999)","volume":"39","author":"Biggar","year":"2005","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0225","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canep.2011.07.004","article-title":"Impact of using multiple causes of death codes to compute site-specific, death certificate-based cancer mortality statistics in the United States","volume":"36","author":"Fink","year":"2012","journal-title":"Cancer Epidemiol."},{"issue":"4","key":"10.1016\/j.canep.2017.11.004_bib0230","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2188\/jea.JE20150010","article-title":"Accuracy of Death Certificates and Assessment of Factors for Misclassification of Underlying Cause of Death","volume":"26","author":"Mieno","year":"2016","journal-title":"J. Epidemiol.\/Jpn. Epidemiol. Assoc."},{"issue":"5","key":"10.1016\/j.canep.2017.11.004_bib0235","doi-asserted-by":"crossref","first-page":"e97714","DOI":"10.1371\/journal.pone.0097714","article-title":"Death certificates underestimate infections as proximal causes of death in the U. S","volume":"9","author":"Govindan","year":"2014","journal-title":"PloS one"},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.canep.2012.08.007","article-title":"The impact of National Death Index linkages on population-based cancer survival rates in the United States","volume":"37","author":"Johnson","year":"2013","journal-title":"Cancer Epidemiol."},{"issue":"Suppl 4","key":"10.1016\/j.canep.2017.11.004_bib0245","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.aids.0000390705.73759.2c","article-title":"Postexposure prophylaxis, preexposure prophylaxis or universal test and treat: the strategic use of antiretroviral drugs to prevent HIV acquisition and transmission","volume":"24","author":"Weber","year":"2010","journal-title":"AIDS (London, England)"},{"issue":"17","key":"10.1016\/j.canep.2017.11.004_bib0250","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1097\/QAD.0b013e32835935b3","article-title":"Exposure to antiretroviral therapy and risk of cancer in HIV-infected persons","volume":"26","author":"Chao","year":"2012","journal-title":"AIDS (London, England)"},{"issue":"14","key":"10.1016\/j.canep.2017.11.004_bib0255","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1097\/QAD.0b013e3282ed6338","article-title":"Risk of cancers during interrupted antiretroviral therapy in the SMART study","volume":"21","author":"Silverberg","year":"2007","journal-title":"AIDS (London, England)"},{"issue":"3","key":"10.1016\/j.canep.2017.11.004_bib0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0163-7258(98)00010-2","article-title":"Chemopreventive agents: protease inhibitors","volume":"78","author":"Kennedy","year":"1998","journal-title":"Pharmacol. Ther."},{"issue":"24","key":"10.1016\/j.canep.2017.11.004_bib0265","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/sj.onc.1208562","article-title":"Inhibition of endogenous reverse transcriptase antagonizes human tumor growth","volume":"24","author":"Sciamanna","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canep.2017.11.004_bib0270","unstructured":"Information for Health Professionals. U.S. Preventive Services Task Force. September 2017. http:\/\/www.uspreventiveservicestaskforce.org\/Page\/Name\/tools-and-resources-for-better-preventive-care (Accessed November 1 2017)."},{"issue":"1","key":"10.1016\/j.canep.2017.11.004_bib0275","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3322\/caac.21261","article-title":"Cancer screening in the United States, 2015: a review of current American cancer society guidelines and current issues in cancer screening","volume":"65","author":"Smith","year":"2015","journal-title":"CA. Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.canep.2017.11.004_bib0280","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s11904-011-0085-5","article-title":"Cancer screening in patients infected with HIV","volume":"8","author":"Sigel","year":"2011","journal-title":"Curr. HIV\/AIDS Rep."},{"issue":"2","key":"10.1016\/j.canep.2017.11.004_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11904-009-0013-0","article-title":"Screening HIV-infected patients for non-AIDS-defining malignancies","volume":"6","author":"Phillips","year":"2009","journal-title":"Curr. HIV\/AIDS Rep."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782117301959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782117301959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T02:34:46Z","timestamp":1659926086000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782117301959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":57,"alternative-id":["S1877782117301959"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2017.11.004","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing temporal trends in non-AIDS cancer mortality among people diagnosed with AIDS: San Francisco, California, 1996\u20132013","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}